Post-transcriptional regulation of IL-6 production by Zc3H12A in fibroblast-like synovial cells

Clinical and Experimental Rheumatology

Volumn 29, Issue 6, 2011, Pages 906-912

  Koga, Tomohiro ^a   Yamasaki, Satoshi ^a   Migita, Kiyoshi ^b   Kita, Junko ^a   Okada, Akitomo ^a   Kawashiri, Shinya ^a   Iwamoto, Naoki ^a   Tatnai, Mami ^a   Arima, Kazuhiko ^a   Origuchi, Tomoki ^a   Nakamura, Hideki ^a   Osaki, Makoto ^a   Tsurumoto, Toshiyuki ^a   Shindo, Hiroyuki ^a   Eguchi, Katsumi ^a   Kawakami, Atsushi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Department of Rheumatology   (Japan)

Author keywords

IL 6; Rheumatoid arthritis; Synoviocyte; Zc3h12a

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; PROTEIN ZC3H12A; RNA BINDING PROTEIN; SMALL INTERFERING RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FIBROBLAST; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SYNOVIOCYTE; WESTERN BLOTTING;

ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-6; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SYNOVIAL MEMBRANE; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84857526542     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. LEE DM, WEINBLATT ME: Rheumatoid arthritis. Lancet 2001;358:903-11. (Pubitemid 32900579)
2. CHOY EH, ISENBERG DA, GARROOD T et al.: Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum 2002;46:3143-50. (Pubitemid 35453522)
3. NISHIMOTO N, YOSHIZAKI K, MIYASAKA N et al.: Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebocontrolled trial. Arthritis Rheum 2004;50:1761-69. (Pubitemid 38725087)
4. MIMA T, NISHIMOTO N: Clinical value of blocking IL-6 receptor. Curr Opin Rheumatol 2009;21:224-30.
5. SMOLEN JS, BEAULIEU A, RUBBERT-ROTH A et al.: Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a doubleblind, placebo-controlled, randomised trial. Lancet 2008;371:987-97. (Pubitemid 351392039)
6. NISHIMOTO N, HASHIMOTO J, MIYASAKA N et al.: Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an X ray readerblinded randomised controlled trial of tocilizumab. Ann Rheum Dis 2007;66:1162-7. (Pubitemid 47309731)
7. HASHIZUME M, HAYAKAWA N, MIHARA M: IL-6 trans-signalling directly induces RAN-KL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alfa and 1L-17. Rheumatology 2008;47:1635-40.
8. ANDERSON P: Post-transcriptional control of cytokine production. Nat Immunol 2008;9:353-9. (Pubitemid 351405104)
9. MATSUSHITA K, TAKEUCHI O, STANDLEY DM et al.: Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 2009;458:1185-90.
10. ZHOU L, AZFER A, NIU J et al.: Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ Res 2006;98:1177-85. (Pubitemid 43948104)
11. LIANG J, WANG J, AZFER A et al.: A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J Biol Chem 2008;283:6337-46.
12. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
13. YAMASAKI S, NAKASHIMA T, KAWAKAMI A et al.: Functional changes in rheumatoid fibroblast-like synovial cells through activation of peroxisome proliferator-activated receptor gamma-mediated signalling pathway. Clin Exp Immunol 2002;129:379-84.
14. LIANG J, WANG J, AZFER A et al.: A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J Biol Chem 2008;283:6337-46.
15. AGGARWAL BB, KUNNUMAKKARA AB, HARIKUMAR KB et al.: Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N y Acad Sci 2009;1171:59-76.
16. MIHARA M, MORIYA Y, KISHIMOTO T, OHSUGI Y: Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 1995;34:321-5.
17. OKAZAKI Y, SAWADA T, NAGATANI K et al.: Effect of nuclear factor-kappaB inhibition on rheumatoid fibroblast-like synoviocytes and collagen induced arthritis. J Rheumatol 2005;32:1440-7. (Pubitemid 41113962)
18. GEORGANAS C, LIU H, PERLMAN H, HOFF-MANN A, THIMMAPAYA B, POPE RM: Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun. J Immunol 2000;165:7199-206. (Pubitemid 32001197)
19. CHEN YL, HUANG YL, LIN NY, CHEN HC, CHIU WC, CHANG CI: Differential regulation of ARE-mediated TNF-alpha and IL-1-beta mRNA stability by lipopolysaccharide in RAW264.7 cells. Biochem Biophys Res Commun 2006;346:160-8.
20. PIECYK M, WAX S, BECK AR, KEDERSHA N, GUPTA M, MARITIM B: TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J 2000;19:4154-63. (Pubitemid 30608553)
21. CARBALLO E, LAI WS, BLACKSHEAR PJ: Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 2000;95:1891-9. (Pubitemid 30151623)
22. BARTOK B, FIRESTEIN GS: Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010;233:233-55.
23. NAKAHARA H, SONG J, SUGIMOTO M et al.: Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum 2003;48:1521-9. (Pubitemid 36682359)
24. NISHIMOTO N, ITO A, ONO M et al.: IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor. Int Immunol 2000;12:187-93. (Pubitemid 30088311)
25. AUPPERLE KR, BENNETT BL, BOYLE DL, TAK PP, MANNING AM, FIRESTEIN GS: NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytes. J Immunol 1999;163:427-33. (Pubitemid 29295870)
26. JONES MR, QUINTON LJ, BLAHNA MT et al.: Zcchc 11-dependent uridylation of micro-RNA directs cytokine expression. Nat Cell Biol 2009;11:1157-63.
27. MINODA Y, SAEKI K, AKI D et al.: A novel zinc finger protein, ZCCHC 11, interacts with TIFA and modulates TLR signaling. Biochem Biophys Res Commun 2006;344:1023-30.